GOCO - GoHealth, Inc. Stock Analysis | Stock Taper
Logo
GoHealth, Inc.

GOCO

GoHealth, Inc. NASDAQ
$1.37 -4.86% (-0.07)

Market Cap $39.34 M
52w High $17.01
52w Low $1.37
P/E -0.08
Volume 26.40K
Outstanding Shares 28.71M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q3-2025 $34.19M $302.01M $-165.85M -485.13% $-13.52 $-262.62M
Q2-2025 $94.05M $161.02M $-54.28M -57.71% $-5.1 $-73.2M
Q1-2025 $220.97M $190.79M $-4.41M -1.99% $-0.52 $33.75M
Q4-2024 $389.13M $256.63M $25.51M 6.56% $2.42 $105.03M
Q3-2024 $118.29M $137.45M $6.78M 5.73% $0.58 $60.86M

What's going well?

There are very few positives this quarter. The company managed to cut sales and marketing expenses, and a higher share count may have brought in some cash.

What's concerning?

Revenue plunged 64%, gross profit collapsed, and losses tripled. Expenses are out of control, and the company is burning cash fast. Shareholder dilution is also a concern.

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q3-2025 $32.08M $1.03B $1.04B $68.17M
Q2-2025 $35.59M $1.31B $977.08M $246.66M
Q1-2025 $22.15M $1.38B $931.06M $295.55M
Q4-2024 $40.92M $1.49B $1.03B $294.8M
Q3-2024 $35.53M $1.34B $943.87M $264.06M

What's financially strong about this company?

There is no goodwill or intangible asset risk, and most assets are in cash or receivables, which are easier to turn into cash if collected.

What are the financial risks or weaknesses?

The company has negative equity, very little cash, and a huge jump in receivables, suggesting customers may not be paying. Debt is high and rising, and liquidity has collapsed.

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q3-2025 $-165.85M $-32.22M $-2.37M $30.99M $-3.51M $-34.59M
Q2-2025 $-115.99M $-37.82M $-2.83M $53.86M $13.44M $-40.65M
Q1-2025 $-9.79M $-12.4M $-3.05M $-3.2M $-18.77M $-15.45M
Q4-2024 $57.98M $14.6M $-2.22M $-6.97M $5.39M $12.39M
Q3-2024 $-30.08M $-12.23M $13.28M $20.33M $21.4M $-16.48M

What's strong about this company's cash flow?

Cash burn is shrinking, and the company was able to collect a large amount of receivables, which temporarily improved cash flow. Capital spending is low, so less cash is needed for maintenance.

What are the cash flow concerns?

GOCO is still losing money and burning cash from operations, with no sign of self-sufficiency. The company depends on borrowing to survive, and the recent cash boost is likely a one-time event.

Revenue by Products

Product Q4-2024Q1-2025Q2-2025Q3-2025
Agency Revenue
Agency Revenue
$0 $0 $80.00M $30.00M
Commission
Commission
$200.00M $170.00M $0 $0
Medicare Revenue
Medicare Revenue
$0 $0 $90.00M $30.00M
Product and Service Other
Product and Service Other
$0 $0 $10.00M $10.00M

Q3 2025 Earnings Call Summary

Read Call Summary

5-Year Trend Analysis

A comprehensive look at GoHealth, Inc.'s financial evolution and strategic trajectory over the past five years.

+ Strengths

GoHealth’s key strengths are its improving income statement, strong gross economics, and sophisticated technology platform tailored to a complex and growing Medicare market. The company has demonstrated that it can grow revenue again after a setback, materially improve margins, and leverage data and AI to enhance both agent productivity and consumer experience. It also maintains meaningful carrier relationships and a recognizable brand in its niche.

! Risks

The main risks center on financial fragility and competitive intensity. The balance sheet shows rising leverage and thinning liquidity, while cash flow has swung back to significant outflows despite better reported margins. Accumulated losses and declining retained earnings signal that past difficulties still weigh on the capital structure. At the same time, GoHealth faces aggressive competition, regulatory uncertainty, and execution risk as it expands into value-based care and new product areas.

Outlook

The overall trajectory looks cautiously constructive but not yet secure. Operational metrics and profitability trends point to a real turnaround, and the strategic shift toward a more integrated, data-driven health platform offers meaningful long-term opportunity. However, the company still needs to prove it can convert this improving profile into durable free cash flow, reduced leverage, and a stronger balance sheet. Future performance will depend heavily on disciplined execution, stable regulatory conditions, and the company’s ability to defend and deepen its competitive advantages.